DUONG, H., YI, Y. W., KANG, H. J., BAE, I., JANG, Y., KWAK, S., & SEONG, Y. (2014). Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells. D.A. Spandidos.
Citação norma ChicagoDUONG, HONG-QUAN, YONG WEON YI, HYO JIN KANG, INSOO BAE, YOUNG-JOO JANG, SAHNG-JUNE KWAK, and YEON-SUN SEONG. Combination of Dasatinib and Gemcitabine Reduces the ALDH1A1 Expression and the Proliferation of Gemcitabine-resistant Pancreatic Cancer MIA PaCa-2 Cells. D.A. Spandidos, 2014.
Citação norma MLADUONG, HONG-QUAN, et al. Combination of Dasatinib and Gemcitabine Reduces the ALDH1A1 Expression and the Proliferation of Gemcitabine-resistant Pancreatic Cancer MIA PaCa-2 Cells. D.A. Spandidos, 2014.